ZA953236B - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number: ZA953236B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical formulations; formulations; pharmaceutical
Prior art date: 1994-04-23

Application number

ZA953236A

Other languages

English (en)

Inventor

Creighton Pierce Conley

Mccreath Davidson

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-04-23

Filing date

1995-04-21

Publication date

1995-12-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10754044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA953236(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-04-21 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

1995-12-27 Publication of ZA953236B publication Critical patent/ZA953236B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

ZA953236A 1994-04-23 1995-04-21 Pharmaceutical formulations ZA953236B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9408117A GB9408117D0 (en)	1994-04-23	1994-04-23	Pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
ZA953236B true ZA953236B (en)	1995-12-27

Family

ID=10754044

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA953236A ZA953236B (en)	1994-04-23	1995-04-21	Pharmaceutical formulations

Country Status (35)

Country	Link
US (1)	US6051255A (xx)
EP (5)	EP0761218B1 (xx)
JP (1)	JP3622975B2 (xx)
CN (1)	CN1134258C (xx)
AP (2)	AP564A (xx)
AT (6)	ATE196845T1 (xx)
AU (1)	AU684949B2 (xx)
BG (1)	BG62842B1 (xx)
BR (1)	BR9507502A (xx)
CA (1)	CA2188496A1 (xx)
CZ (2)	CZ294168B6 (xx)
DE (5)	DE29522153U1 (xx)
DK (4)	DK1093813T3 (xx)
DZ (1)	DZ1876A1 (xx)
ES (4)	ES2161288T3 (xx)
FI (1)	FI964249L (xx)
GB (1)	GB9408117D0 (xx)
GR (2)	GR3035031T3 (xx)
HK (1)	HK1050992A1 (xx)
HU (1)	HU228399B1 (xx)
IL (1)	IL113433A (xx)
MA (1)	MA23528A1 (xx)
MY (1)	MY115351A (xx)
NO (1)	NO310703B1 (xx)
NZ (1)	NZ285080A (xx)
OA (1)	OA10377A (xx)
PL (1)	PL316966A1 (xx)
PT (4)	PT758235E (xx)
RO (1)	RO116997B1 (xx)
RU (1)	RU2152213C1 (xx)
SA (1)	SA95160343B1 (xx)
SI (1)	SI0758235T1 (xx)
SK (1)	SK282594B6 (xx)
WO (1)	WO1995028927A1 (xx)
ZA (1)	ZA953236B (xx)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9407386D0 (en)	1994-04-14	1994-06-08	Smithkline Beecham Plc	Pharmaceutical formulation
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
DZ2028A1 (fr) *	1995-05-03	2002-10-23	Smithkline Beecham Plc	Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) *	1995-06-06	2003-06-12	Smithkline Beecham P.L.C.	Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
NZ337247A (en) *	1995-09-07	2001-05-25	Smithkline Beecham Corp	Pharmaceutical tablet formulation comprising 875mg amoxycillin
AT403375B (de) *	1995-11-15	1998-01-26	Biochemie Gmbh	Verfahren zur fällung von alkalisalzen der clavulansäure
AT407701B (de) *	1996-08-12	2001-05-25	Biochemie Gmbh	Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
TWI225402B (en) *	1996-03-13	2004-12-21	Biochemie Gmbh	Auxiliary-free agglomerates
GB9613470D0 (en)	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
GB9616536D0 (en)	1996-08-06	1996-09-25	Quadrant Holdings Cambridge	Co-amoxiclav dosage form
GB9617780D0 (en) *	1996-08-24	1996-10-02	Smithkline Beecham Plc	Method of treatment
WO1998034598A2 (en) *	1997-02-07	1998-08-13	Gist-Brocades B.V.	Homogeneous granulated formulations for dose sipping technology
CA2280857A1 (en) *	1997-02-14	1998-08-20	Smithkline Beecham Laboratoires Pharmaceutiques	Pharmaceutical formulations comprising amoxocyllin and clavulanate
US20030124187A1 (en) *	1997-02-14	2003-07-03	Smithkline Beecham Laboratoires Pharmaceutiques,	Pharmaceutical formulations comprising amoxycillin and clavulanate
AU9540898A (en) *	1997-08-29	1999-03-22	Dsm N.V.	Granules free of excipients
US6395298B1 (en)	1997-10-31	2002-05-28	Pharmacia Corporation	Gellan gum tablet coating
CN1209099C (zh)	1999-04-01	2005-07-06	Dsm公司	结晶化附聚物
EP1044680B1 (en) *	1999-04-13	2003-06-11	Beecham Pharmaceuticals (Pte) Limited	Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate
US7250176B1 (en) *	1999-04-13	2007-07-31	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection
US6878386B1 (en)	1999-04-13	2005-04-12	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en)	1999-04-13	2001-09-25	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising administering amoxycillin
US20040038948A1 (en)	1999-12-07	2004-02-26	Uhrich Kathryn E.	Therapeutic compositions and methods
GB9930578D0 (en) *	1999-12-23	2000-02-16	Smithkline Beecham Plc	Pharmaceutical formulations
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6565882B2 (en) *	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
WO2002002081A1 (en) *	2000-07-05	2002-01-10	Capricorn Pharma, Inc.	Rapid-melt semi-solid compositions, methods of making same and methods of using same
US6375982B1 (en) *	2000-07-05	2002-04-23	Capricorn Pharma, Inc.	Rapid-melt semi-solid compositions, methods of making same and method of using same
AU2001292185A1 (en) *	2000-10-12	2002-04-22	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin
US6756057B2 (en)	2000-10-12	2004-06-29	Beecham Pharmaceuticals (Pte) Limited	Amoxicillin and potassium clavulanate dosage form
US20020068078A1 (en) *	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US6541014B2 (en) *	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20020197314A1 (en) *	2001-02-23	2002-12-26	Rudnic Edward M.	Anti-fungal composition
MXPA03008997A (es) *	2001-04-10	2004-02-12	Sun Pharmaceutical Ind Ltd	Composicion de liberacion por impulso temporizado.
US20030070584A1 (en) *	2001-05-15	2003-04-17	Cynthia Gulian	Dip coating compositions containing cellulose ethers
AU4061702A (en) *	2001-05-15	2003-04-03	Mcneil-Ppc, Inc.	Dip coating compositions containing starch or dextrin
US8309118B2 (en) *	2001-09-28	2012-11-13	Mcneil-Ppc, Inc.	Film forming compositions containing sucralose
AU2003210925A1 (en) *	2002-02-07	2003-09-02	Rutgers, The State University	Antibiotic polymers
GB0203528D0 (en) *	2002-02-14	2002-04-03	Glaxo Group Ltd	Process and composition
ES2263949T3 (es) *	2002-02-14	2006-12-16	Glaxo Group Limited	Composicion farmaceutica que comprende n-((1-n-butil-4-piperidinil)mentil)-3,4-dihidro-2h-(1,3)oxazino (3,2-aindol-10-carboxamida o una sal de la misma y procedimiento para su preparacon que comprende granulacion por via seca.
US20060083759A1 (en) *	2002-07-17	2006-04-20	Aleksander Resman	Stabilization of the profile of release of active substances from a formulation
US8637512B2 (en)	2002-07-29	2014-01-28	Glaxo Group Limited	Formulations and method of treatment
KR100456833B1 (ko) *	2002-08-01	2004-11-10	주식회사 대웅	아목시실린 및 클라불라네이트를 함유하는 유핵정
US7429619B2 (en) *	2002-08-02	2008-09-30	Mcneil Consumer Healthcare	Polyacrylic film forming compositions
CA2406592C (en) *	2002-10-04	2003-09-30	Duchesnay Inc.	Method of preparing pharmaceutical dosage forms containing multiple active ingredients
US7405210B2 (en)	2003-05-21	2008-07-29	Osi Pharmaceuticals, Inc.	Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
WO2005009368A2 (en)	2003-07-21	2005-02-03	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
JP2006528185A (ja) *	2003-07-21	2006-12-14	アドバンシスファーマスーティカルコーポレイション	抗生物質製剤、その使用法及び作成方法
EP1648415A4 (en) *	2003-07-21	2011-11-16	Middlebrook Pharmaceuticals Inc	ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2535177A1 (en) *	2003-08-11	2005-02-24	Advancis Pharmaceutical Corporation	Robust pellet
CA2535398C (en)	2003-08-12	2013-11-12	Advancis Pharmaceuticals Corporation	Antibiotic product, use and formulation thereof
WO2005023184A2 (en) *	2003-08-29	2005-03-17	Advancis Pharmaceuticals Corporation	Antibiotic product, use and formulation thereof
DE10341264A1 (de) *	2003-09-04	2005-03-24	Grünenthal GmbH	Schmelzformulierte, multipartikuläre orale Darreichungsform
AU2004273830B2 (en) *	2003-09-15	2011-03-24	Shionogi, Inc.	Antibiotic product, use and formulation thereof
EP1701705A4 (en) *	2003-12-24	2007-08-08	Advancis Pharmaceutical Corp	IMPROVED ABSORPTION OF DOSAGE FORMS WITH MODIFIED RELEASE
ATE483708T1 (de)	2004-03-08	2010-10-15	Prosidion Ltd	Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
EP1771158A4 (en) *	2004-07-02	2008-03-12	Advancis Pharmaceutical Corp	TABLET FOR PULSE DISTRIBUTION
KR100638315B1 (ko) *	2004-07-23	2006-10-25	주식회사 대웅제약	다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
KR101318032B1 (ko)	2005-05-20	2013-10-14	다이이찌 산쿄 가부시키가이샤	필름 코팅 제제
KR100780553B1 (ko) *	2005-08-18	2007-11-29	한올제약주식회사	메트포르민 서방정 및 그의 제조방법
US8778924B2 (en) *	2006-12-04	2014-07-15	Shionogi Inc.	Modified release amoxicillin products
US8357394B2 (en)	2005-12-08	2013-01-22	Shionogi Inc.	Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en)	2006-05-05	2012-10-30	Shionogi Inc.	Pharmaceutical compositions and methods for improved bacterial eradication
CL2008003230A1 (es) *	2007-11-01	2009-11-27	Sanofi Aventis Healthcare Pty Ltd	Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
SI2477611T1 (sl) *	2009-09-18	2017-07-31	Sanofi	Formulacije tablete (Z)-2-ciano-3-hidroksi-but-2-enojska kislina-(4'-trifluormetilfenil)-amida z izboljšano stabilnostjo
TR200909787A2 (tr)	2009-12-25	2011-07-21	Bi̇lgi̇ç Mahmut	Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000686A1 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000687A1 (tr)	2010-01-29	2011-08-22	Bi̇lgi̇ç Mahmut	Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000688A2 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
JP6041591B2 (ja) *	2011-09-13	2016-12-14	大日本住友製薬株式会社	イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
US9387250B2 (en)	2013-03-15	2016-07-12	Rutgers, The State University Of New Jersey	Therapeutic compositions for bone repair

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1241844A (en)	1968-08-23	1971-08-04	Beecham Group Ltd	Penicillins
GB1508977A (en)	1974-04-20	1978-04-26	Beecham Group Ltd	Beta-lactam antibiotic from streptomyces clavuligerus
US4098897A (en) *	1975-04-14	1978-07-04	Beecham Group Limited	Anti bacterial agents
JO984B1 (en) *	1977-10-11	1979-12-01	بيتشام غروب ليمتد	A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) *	1980-09-27	1983-12-16	Beecham Group Ltd	Tablet containing amoxycillin and potassium clavulanate
EP0080862B1 (en) *	1981-12-02	1985-09-25	Beecham Group Plc	Pharmaceutical formulation comprising beta-lactam antibiotics
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
EP1044680B1 (en) *	1999-04-13	2003-06-11	Beecham Pharmaceuticals (Pte) Limited	Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate
AU2001292185A1 (en) *	2000-10-12	2002-04-22	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin

1994
- 1994-04-23 GB GB9408117A patent/GB9408117D0/en active Pending
1995
- 1995-04-13 AP APAP/P/1995/000733A patent/AP564A/en active
- 1995-04-19 CZ CZ19963090A patent/CZ294168B6/cs not_active IP Right Cessation
- 1995-04-19 DK DK00204182T patent/DK1093813T3/da active
- 1995-04-19 PL PL95316966A patent/PL316966A1/xx unknown
- 1995-04-19 ES ES95917937T patent/ES2161288T3/es not_active Expired - Lifetime
- 1995-04-19 AP APAP/P/1996/000868A patent/AP9600868A0/en unknown
- 1995-04-19 DE DE29522153U patent/DE29522153U1/de not_active Expired - Lifetime
- 1995-04-19 ES ES00204182T patent/ES2182754T3/es not_active Expired - Lifetime
- 1995-04-19 CZ CZ200011418U patent/CZ11376U1/cs not_active IP Right Cessation
- 1995-04-19 AT AT96202848T patent/ATE196845T1/de not_active IP Right Cessation
- 1995-04-19 CA CA002188496A patent/CA2188496A1/en not_active Abandoned
- 1995-04-19 FI FI964249A patent/FI964249L/fi not_active Application Discontinuation
- 1995-04-19 US US08/727,581 patent/US6051255A/en not_active Expired - Lifetime
- 1995-04-19 EP EP96202848A patent/EP0761218B1/en not_active Revoked
- 1995-04-19 ES ES96202848T patent/ES2152485T3/es not_active Expired - Lifetime
- 1995-04-19 HU HU9602922A patent/HU228399B1/hu unknown
- 1995-04-19 EP EP02076874A patent/EP1243267A3/en not_active Withdrawn
- 1995-04-19 BR BR9507502A patent/BR9507502A/pt not_active IP Right Cessation
- 1995-04-19 DE DE69519093T patent/DE69519093T2/de not_active Expired - Fee Related
- 1995-04-19 DK DK95917937T patent/DK0758235T3/da active
- 1995-04-19 AT AT95917937T patent/ATE203161T1/de active
- 1995-04-19 PT PT95917937T patent/PT758235E/pt unknown
- 1995-04-19 CN CNB951934023A patent/CN1134258C/zh not_active Expired - Lifetime
- 1995-04-19 RU RU96122474/14A patent/RU2152213C1/ru active
- 1995-04-19 PT PT99200891T patent/PT978276E/pt unknown
- 1995-04-19 JP JP52733495A patent/JP3622975B2/ja not_active Expired - Lifetime
- 1995-04-19 EP EP99200891A patent/EP0978276B1/en not_active Expired - Lifetime
- 1995-04-19 DE DE69521799T patent/DE69521799T2/de not_active Expired - Lifetime
- 1995-04-19 ES ES99200891T patent/ES2180251T3/es not_active Expired - Lifetime
- 1995-04-19 SK SK1354-96A patent/SK282594B6/sk not_active IP Right Cessation
- 1995-04-19 WO PCT/EP1995/001463 patent/WO1995028927A1/en not_active Ceased
- 1995-04-19 AU AU24068/95A patent/AU684949B2/en not_active Expired
- 1995-04-19 AT AT00204182T patent/ATE226074T1/de not_active IP Right Cessation
- 1995-04-19 DE DE69528204T patent/DE69528204T2/de not_active Expired - Lifetime
- 1995-04-19 DK DK99200891T patent/DK0978276T3/da active
- 1995-04-19 AT AT99200891T patent/ATE223706T1/de active
- 1995-04-19 EP EP95917937A patent/EP0758235B1/en not_active Expired - Lifetime
- 1995-04-19 RO RO96-02030A patent/RO116997B1/ro unknown
- 1995-04-19 SI SI9530526T patent/SI0758235T1/xx unknown
- 1995-04-19 DK DK96202848T patent/DK0761218T3/da active
- 1995-04-19 PT PT00204182T patent/PT1093813E/pt unknown
- 1995-04-19 NZ NZ285080A patent/NZ285080A/en not_active IP Right Cessation
- 1995-04-19 EP EP00204182A patent/EP1093813B1/en not_active Revoked
- 1995-04-19 PT PT96202848T patent/PT761218E/pt unknown
- 1995-04-19 DE DE69528608T patent/DE69528608T2/de not_active Revoked
- 1995-04-20 MY MYPI95001037A patent/MY115351A/en unknown
- 1995-04-20 IL IL11343395A patent/IL113433A/xx unknown
- 1995-04-21 MA MA23858A patent/MA23528A1/fr unknown
- 1995-04-21 ZA ZA953236A patent/ZA953236B/xx unknown
- 1995-04-22 DZ DZ950044A patent/DZ1876A1/fr active
- 1995-10-25 SA SA95160343A patent/SA95160343B1/ar unknown
1996
- 1996-10-22 NO NO19964488A patent/NO310703B1/no not_active IP Right Cessation
- 1996-10-23 OA OA60908A patent/OA10377A/en unknown
- 1996-10-23 BG BG100933A patent/BG62842B1/bg unknown
1998
- 1998-09-21 HK HK03101681.9A patent/HK1050992A1/en unknown
2000
- 2000-07-18 AT AT0052400U patent/AT5349U1/de not_active IP Right Cessation
- 2000-12-12 GR GR20000402718T patent/GR3035031T3/el not_active IP Right Cessation
2001
- 2001-04-11 AT AT0028501U patent/AT5350U1/de not_active IP Right Cessation
- 2001-10-09 GR GR20010401708T patent/GR3036844T3/el unknown

Also Published As

Publication number	Publication date
DE69528204D1 (de)	2002-10-17
EP0978276B1 (en)	2002-09-11
DE29522153U1 (de)	2000-04-06
FI964249A7 (fi)	1996-10-22
HK1027024A1 (en)	2001-01-05
DE69519093T2 (de)	2001-07-19
WO1995028927A1 (en)	1995-11-02
JPH09512027A (ja)	1997-12-02
AT5349U1 (de)	2002-06-25
DE69528608T2 (de)	2003-06-26
EP0978276A3 (en)	2000-04-12
ATE226074T1 (de)	2002-11-15
DE69528204T2 (de)	2003-08-07
CN1149829A (zh)	1997-05-14
IL113433A (en)	2003-06-24
DK1093813T3 (da)	2003-02-17
NZ285080A (en)	1998-05-27
EP1243267A2 (en)	2002-09-25
CZ309096A3 (en)	1997-04-16
EP1243267A3 (en)	2002-10-30
HK1009936A1 (en)	1999-06-11
BG100933A (en)	1997-07-31
DK0758235T3 (da)	2001-10-29
HK1036404A1 (en)	2002-01-04
OA10377A (en)	2001-11-21
AT5350U1 (de)	2002-06-25
IL113433A0 (en)	1995-07-31
HUT76335A (en)	1997-08-28
DE69521799D1 (de)	2001-08-23
NO964488D0 (no)	1996-10-22
ATE196845T1 (de)	2000-10-15
AP9600868A0 (en)	1996-10-31
PT758235E (pt)	2001-10-31
GR3035031T3 (en)	2001-03-30
SK135496A3 (en)	1997-05-07
DE69521799T2 (de)	2002-06-13
SA95160343B1 (ar)	2005-05-04
US6051255A (en)	2000-04-18
AP564A (en)	1996-11-21
EP0758235A1 (en)	1997-02-19
GR3036844T3 (en)	2002-01-31
HU9602922D0 (en)	1996-12-30
CA2188496A1 (en)	1995-11-02
CN1134258C (zh)	2004-01-14
JP3622975B2 (ja)	2005-02-23
EP1093813A3 (en)	2001-05-30
EP1093813B1 (en)	2002-10-16
ATE223706T1 (de)	2002-09-15
PL316966A1 (en)	1997-03-03
PT761218E (pt)	2001-03-30
HK1021860A1 (en)	2000-07-07
CZ11376U1 (cs)	2001-07-12
AU684949B2 (en)	1998-01-08
ES2161288T3 (es)	2001-12-01
DZ1876A1 (fr)	2002-02-17
MY115351A (en)	2003-05-31
ES2182754T3 (es)	2003-03-16
EP0758235B1 (en)	2001-07-18
ATE203161T1 (de)	2001-08-15
DK0978276T3 (da)	2003-01-20
FI964249A0 (fi)	1996-10-22
RO116997B1 (ro)	2001-09-28
BG62842B1 (bg)	2000-09-29
EP0978276A2 (en)	2000-02-09
CZ294168B6 (cs)	2004-10-13
BR9507502A (pt)	1997-09-02
GB9408117D0 (en)	1994-06-15
FI964249L (fi)	1996-10-22
MA23528A1 (fr)	1995-12-31
HK1050992A1 (en)	2003-07-18
ES2180251T3 (es)	2003-02-01
DE69519093D1 (de)	2000-11-16
PT978276E (pt)	2003-01-31
ES2152485T3 (es)	2001-02-01
SK282594B6 (sk)	2002-10-08
PT1093813E (pt)	2003-02-28
SI0758235T1 (en)	2001-10-31
EP0761218B1 (en)	2000-10-11
NO310703B1 (no)	2001-08-20
HU228399B1 (en)	2013-03-28
NO964488L (no)	1996-12-17
DK0761218T3 (da)	2000-12-18
EP0761218A1 (en)	1997-03-12
AU2406895A (en)	1995-11-16
AP9500733A0 (en)	1995-04-30
RU2152213C1 (ru)	2000-07-10
EP1093813A2 (en)	2001-04-25
DE69528608D1 (de)	2002-11-21

Publication	Publication Date	Title
AP9500733A0 (en)	1995-04-30	Pharmaceutical formulations
GB9404248D0 (en)	1994-04-20	Pharmaceutical formulations
EG23826A (en)	2007-09-25	Pharmaceutical formulations
GB9523752D0 (en)	1996-01-24	Pharmaceutical formulations
GB9407386D0 (en)	1994-06-08	Pharmaceutical formulation
GB9402203D0 (en)	1994-03-30	Pharmaceutical formulation
IL112521A0 (en)	1995-05-26	Pharmaceutical formulation
GB9405856D0 (en)	1994-05-11	Pharmaceutical formulation
GB9416599D0 (en)	1994-10-12	Pharmaceutical formulation
GB9408053D0 (en)	1994-06-15	Pharmaceutical preparation
GB9323399D0 (en)	1994-01-05	Pharmaceutical formulations
GB9311030D0 (en)	1993-07-14	Pharmaceutical formulations
ZA96392B (en)	1996-08-29	Pharmaceutical formulations
GB9413542D0 (en)	1994-08-24	Pharmaceutical formulations
GB9500978D0 (en)	1995-03-08	Pharmaceutical formulations
ZA953239B (en)	1996-01-03	Pharmaceutical formulations
GB9408151D0 (en)	1994-06-15	Pharmaceutical formulations
GB9408161D0 (en)	1994-06-15	Pharmaceutical formulations
GB9417953D0 (en)	1994-10-26	Pharmaceutical formulations
GB9408163D0 (en)	1994-06-15	Pharmaceutical formulations
GB9401738D0 (en)	1994-03-23	Pharmaceutical formulations
GB9414216D0 (en)	1994-08-31	Pharmaceutical formulations
GB9408164D0 (en)	1994-06-15	Pharmaceutical formulations
GB9426113D0 (en)	1995-02-22	Pharmaceutical formulations
GB9606372D0 (en)	1996-06-05	Pharmaceutical formulations